Top Markets
#1 MarsCoin MarsCoin +46.67%
#2 Palladium Network Palladium Network +27.97%
#3 Siren Siren +27.76%
#4 Status Status +19.63%
#5 Useless Coin Useless Coin +18.72%
#6 Bedrock Bedrock +15.94%
#7 BankrCoin BankrCoin +15.33%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
#9 Ankr Network Ankr Network +13.10%
#10 Arweave Arweave +10.04%
Coin of the day
MarsCoin MarsCoin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Orchard Therapeutics plc Orchard Therapeutics plc

Orchard Therapeutics plc

ORTX
Rangering i aksjer #18159
Orchard Therapeutics plc is a biopharmaceutical firm dedicated to developing... Orchard Therapeutics plc is a biopharmaceutical firm dedicated to developing gene-based treatments for severe and often fatal rare conditions, operating across the United Kingdom, European Union, and the United States. Their innovative gene therapy strategy involves modifying a patient's own hematopoietic stem cells, converting them into a therapeutic cellular drug that can address the illness with just one dose. The company markets Strimvelis, a gammaretroviral therapy approved for treating adenosine deaminase-severe combined immunodeficiency (ADA-SCID). Orchard's clinical pipeline features several investigational therapies, including OTL-101 for ADA-SCID, OTL-200 targeting metachromatic leukodystrophy, OTL-103 for Wiskott-Aldrich syndrome, OTL-102 for X-linked chronic granulomatous disease, and OTL-300 for transfusion-dependent beta-thalassemia. Early-stage research programs encompass OTL-203 for mucopolysaccharidosis type I, OTL-201 for MPS-IIIA, and OTL-202 for MPS IIIB. Furthermore, a strategic partnership with Pharming Group N.V. covers the research, development, production, and commercialization of OTL-105, an experimental ex vivo autologous hematopoietic stem cell gene therapy designed for hereditary angioedema. Established in 2015 as Orchard Rx Limited, Orchard Therapeutics plc is headquartered in London, UK.
Aksjekurs
$16.70
Sist synkronisert: 2024-02-02
Markedsverdi
$210.34M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
GB
Handel Orchard Therapeutics plc (ORTX)

Kategori

Healthcare
Aksjeprishistorikk for Orchard Therapeutics plc (ORTX)
Høyeste sluttskurs: $16.70 den 2024-02-01

Laveste sluttskurs: $140.00 den 2018-10-01
Aksjeprishistorikk for Orchard Therapeutics plc fra 2018 til 2026
Årlig aksjeprisytelse
År Ytelse
2024 2.11%
2023 292.95%
2022 -67.24%
2021 -72.13%
2020 -65.44%
2019 -7.87%
2018 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $556.43 40.29%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 45.39%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $152.82 535.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $123.39 -8.70%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $757.71 6.76%
CH